�New insight into key players in iron metabolism has yielded a novel tool for distinguishing among root causes of iron overload or deficiency in humans, the researchers report card in the August take of Cell Metabolism, a publication of Cell Press. While the body inevitably iron to produce hb, a substance in red ink blood cells that enables them to carry oxygen, too much iron toilet build up and eventually damage organs.
The equilibrium of branding iron in mammals is controlled by a liver-produced endocrine called hepcidin and the iron transporting receptor ferroportin, researchers knew. Hepcidin binds ferroportin to stimulate its break dispirited, thereby lowering iron export. Too much hepcidin results in anaemia; too slight and the body doesn't rid itself of sufficiency iron. (The most common human disease of iron overload is hereditary hemochromotosis, which affects about five-spot out of 1000 Caucasians in the U.S., according to the National Institutes of Health.)
Now, researchers have identified the critical hepcidin-binding domain (HBD) on ferroportin. By placing that binding website on a bead, they now have a very specific method for sleuthing hepcidin levels in human blood.
"We've identified the hepcidin-binding site," said Jerry Kaplan of the University of Utah, Salt Lake City. "It will grant the diagnosis of underlying inflammation to distinguish diseases of iron metabolism that stem from hepcidin versus those with other causes."
Hepcidin was first known not for its effects on smoothing iron but for its disinfectant action, explained Kaplan and his co-worker Diane Ward, also of the University of Utah. The liver produces more of the hormone in response to inflammatory cytokines as a defense mechanism. Because microorganisms need smoothing iron, increases in hepcidin that lead to a refuse in ferroportin and iron are believed to be antimicrobial, he explained.
In addition to zeroing in on the hepcidin-binding site in the new study, Kaplan and Ward showed that their HBD assay can readily detect variations in serum hepcidin levels due to mutations in genes known to impress hepcidin levels as well as mutations in former genes involved in iron metabolism.
While other tests for hepicidin have been developed, the new assay is alone in that it specifically identifies the hormone's biologically active form. Due to the remarkable degree of evolutionary preservation of the binding website, the new assay could also be used in other vertebrates, from oxen to fish, they aforesaid.
" This quiz narrows it down to [active hepcidin]," Ward added. "It commode help us divine the effects of inflammation on body iron stores."
The researchers made another unexpected discovery. Human hepcidin binds ferroportin at 37? Celsius, but not at 4?. The reason, they establish, is that the hepcidin from humans changes its conformation at low temperatures.
Most mammals never catch that inhuman, so the physiological relevancy wasn't clear. But, the researchers wondered what it might bastardly for other, cold-blooded vertebrates like fish that nates live in very inhuman waters.
They found that the hepcidin of zebrafish continued to bind at low temperatures, despite the fact that the hepcidin-binding domain of the fish was nearly identical to that from humans. The same was true of brown trout collected in the eye of the Utah wintertime, along with Alaskan nine-spine sticklebacks and a toad, they bear witness. The difference between mammals and the fish seems to lie in a portion of the hepcidin structure outside of the binding domain.
Their studies led to another evolutionary insight. Most mammals experience just one hepcidin gene, but fish have multiple, earlier studies had shown. One of the fish hepcidins is a full-length, "mature" hepcidin, while the others ar smaller versions. They now show that the full-length hepcidin of fish has little germicide power against E. coli. Together with earlier evidence, the outcome suggest that mammalian hepcidin has both iron regulative and antimicrobic activity, patch fish hepcidin genes have evolved to separate these two functions, they aforesaid.
The researchers include Ivana De Domenico, University of Utah, Salt Lake City, UT; Elizabeta Nemeth, University of California, Los Angeles, CA ; Jenifer M. Nelson, University of Utah, Salt Lake City, UT; John D. Phillips, University of Utah, Salt Lake City, UT; Richard S. Ajioka, University of Utah, Salt Lake City, UT; Michael S. Kay, University of Utah, Salt Lake City, UT; James P. Kushner, University of Utah, Salt Lake City, UT; Tomas Ganz, University of California, Los Angeles, CA ; Diane M. Ward, University of Utah, Salt Lake City, UT; and Jerry Kaplan, University of Utah, Salt Lake City, UT.
Cell Press
More info
